Caprock Group, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
Caprock Group, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$703,000
+6.2%
16,038
+7.0%
0.07%
+11.3%
Q1 2022$662,000
+77.0%
14,988
+79.0%
0.06%
+100.0%
Q4 2021$374,000
+63.3%
8,371
+47.2%
0.03%
+47.6%
Q2 2021$229,000
-32.4%
5,686
-34.4%
0.02%
-54.3%
Q3 2020$339,000
-69.5%
8,666
-67.9%
0.05%
-72.5%
Q2 2020$1,112,000
+51.3%
26,956
+39.8%
0.17%
+20.1%
Q1 2020$735,000
+114.3%
19,282
+166.7%
0.14%
+127.9%
Q4 2019$343,000
+35.6%
7,230
+23.5%
0.06%
+24.5%
Q3 2019$253,000
+10.5%
5,855
+3.8%
0.05%
+8.9%
Q2 2019$229,000
-18.2%
5,639
-13.4%
0.04%
-16.7%
Q1 2019$280,000
-7.0%
6,512
-16.3%
0.05%
-21.7%
Q4 2018$301,000
+9.1%
7,780
+14.4%
0.07%
+23.2%
Q3 2018$276,000
+7.8%
6,798
+8.5%
0.06%
+3.7%
Q2 2018$256,000
+18.5%
6,264
+15.4%
0.05%
+17.4%
Q1 2018$216,000
-75.2%
5,426
-74.4%
0.05%
-74.6%
Q3 2017$871,000
-6.2%
21,191
-0.4%
0.18%
-12.1%
Q2 2017$929,000
-2.2%
21,279
-5.6%
0.21%
-7.6%
Q1 2017$950,000
+15.6%
22,540
+5.6%
0.22%
+7.7%
Q4 2016$822,000
-56.9%
21,349
-51.7%
0.21%
-52.2%
Q3 2016$1,908,000
-0.8%
44,230
-0.4%
0.43%
-7.7%
Q2 2016$1,924,000
+5.4%
44,390
-1.4%
0.47%
+8.3%
Q1 2016$1,826,00045,0330.43%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders